{"id":616601,"date":"2022-09-16T00:34:03","date_gmt":"2022-09-16T00:34:03","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=616601"},"modified":"2022-09-16T00:34:03","modified_gmt":"2022-09-16T00:34:03","slug":"plaque-psoriasis-market-to-observe-stupendous-growth-during-the-forecast-period-201932delveinsight-key-players-bristol-myers-squibb-sotyktu-amgen-otezla-arcutis-arq151-affibody-akeso","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/plaque-psoriasis-market-to-observe-stupendous-growth-during-the-forecast-period-201932delveinsight-key-players-bristol-myers-squibb-sotyktu-amgen-otezla-arcutis-arq151-affibody-akeso_616601.html","title":{"rendered":"Plaque Psoriasis Market to Observe Stupendous Growth During the Forecast Period (2019-32)-DelveInsight | Key Players – Bristol Myers Squibb (Sotyktu), Amgen (Otezla), Arcutis (ARQ-151), Affibody, Akeso"},"content":{"rendered":"
\n
\"Plaque<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight\u2019s assessment, globally, nearly 75+ key pharma and biotech companies are working in the Plaque Psoriasis therapeutics landscape. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.<\/div>\n

DelveInsight’s “Plaque Psoriasis Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Plaque Psoriasis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/p>\n

The Plaque Psoriasis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Plaque<\/p>\n

Plaque Psoriasis: An Overview<\/strong><\/p>\n

Psoriasis generally refers to a common skin condition that speeds up the life cycle of skin cells. It causes cells to build up rapidly on the surface of the skin. The extra skin cells form scales and red patches that are itchy and sometimes painful.<\/p>\n

Plaque psoriasis is a chronic autoimmune condition. It may be localized or widespread and accounts for most psoriasis cases. it is characterized by red patches of thickened skin (plaques) covered in silver scales. Any body area may be affected, but the main areas are the knees, elbows, lower back, and scalp.<\/em><\/p>\n

Plaque Psoriasis Market Key Facts<\/strong><\/p>\n